Week In Review: Ten Biggest 2022 China Biopharma Deals Worth $21.5 Billion

China Biopharma deal activity in 2022 was certainly slower than the previous year, but the ten largest deals, many of them booked in the second half of the year, totaled a decent $21.5 billion by themselves.